bupropion

Generic: bupropion hydrochloride

Labeler: NCS HealthCare of KY, LLC dba Vangard Labs
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive

Drug Facts

Product Profile

Brand Name bupropion
Generic Name bupropion hydrochloride
Labeler NCS HealthCare of KY, LLC dba Vangard Labs
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

BUPROPION HYDROCHLORIDE 150 mg/1

Identifiers & Regulatory

Product NDC 0615-8262
Product ID 0615-8262_f36c7e1c-d5b0-4d3d-bf68-1e90b113fca4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202304
Marketing Start 2014-11-01
Marketing End 2026-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 06158262
Hyphenated Format 0615-8262

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA202304 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8262-39)
source: ndc

Packages (1)

0615-8262-39 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8262-39)

Ingredients (1)

BUPROPION HYDROCHLORIDE (150 mg/1)

Linked Drug Pages (1)

bupropion ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f36c7e1c-d5b0-4d3d-bf68-1e90b113fca4", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["c5a0636b-229e-45ae-8f2c-50bb21f56d25"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8262-39)", "package_ndc": "0615-8262-39", "marketing_end_date": "20260228", "marketing_start_date": "20190108"}], "brand_name": "bupropion", "product_id": "0615-8262_f36c7e1c-d5b0-4d3d-bf68-1e90b113fca4", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0615-8262", "generic_name": "bupropion hydrochloride", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA202304", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20141101"}